Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Stoke Therapeutics (STOK) Receivables - Other (2021 - 2025)

Stoke Therapeutics has reported Receivables - Other over the past 5 years, most recently at $2.0 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 181.29% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, up 181.29%, while the annual FY2025 figure was $2.0 million, 181.29% up from the prior year.
  • Receivables - Other for Q4 2025 was $2.0 million at Stoke Therapeutics, up from $1.6 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $2.0 million in Q4 2025 and troughed at $11000.0 in Q1 2024.
  • A 5-year average of $588882.4 and a median of $395000.0 in 2022 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: crashed 97.76% in 2024 and later surged 5409.09% in 2025.
  • Year by year, Receivables - Other stood at $132000.0 in 2021, then soared by 345.45% to $588000.0 in 2022, then tumbled by 89.12% to $64000.0 in 2023, then skyrocketed by 993.75% to $700000.0 in 2024, then surged by 181.29% to $2.0 million in 2025.
  • Business Quant data shows Receivables - Other for STOK at $2.0 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.